Discontinued — last reported Q3 '25
Natera, Inc. Accrued Litigation increased by 1.2% to $33.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase indicates higher legal risk or the recognition of new settlement obligations, which can negatively impact earnings.
Accrued litigation represents the estimated liability for legal claims and settlements that are probable and estimable....
Highly specific to the company's legal environment; peers in the pharmaceutical industry often carry similar provisions.
accrued_litigation| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $32.60M | $33.00M |
| QoQ Change | — | +1.2% |